email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

Research Article(ISSN: 2644-1209)

Laser Clot Blast Therapy for Central Retinal Venous Occlusion

Volume 2 - Issue 4

Gurbax Singh*

  • Author Information Open or Close
    • International Eye Research and Cure Centre, India

    *Corresponding author:Gurbax Singh, International Eye Research and Cure Centre, New Delhi, India

Received:November 16, 2019;   Published:November 25, 2019

DOI: 10.32474/TOOAJ.2018.02.000142

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Purpose: To report Yag laser clot blast therapy for central retinal venous occlusion.

Methods & Materials: Prospective study of 10 patients. Best visual acuity was finger counting at 1 meter in all the cases, which were subjected to the treatment. The cases were followed up for 2-4 years (2.5 years).

Results: In 10 cases visual acuity improved to 0.4 (20/50) in 1st week treatment. The best final visual acuity improvement was 20/30 in 8 and 20/40 in 2 cases.

Conclusions: Early Yag laser clot blast therapy is useful for rapid improvement of the visual acuity and prevents the complications secondary to central venous occlusion.

Most of the cases of the occlusion of central retinal vein invariably turned out to be unsuccessful with medical therapy given in the form of fibrinolytic agents, anticoagulants, hemodilution” and steroid4. The cases that present with Ischemic central retinal venous occlusion with visual acuity of 20/200 or less are typically unfavorable’. In most instances, even the laser photocoagulation does not yield a visual benefit compared with the natural course of the diseases. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy has been tried successfully by some67’8 to treat these cases but had led to complications associated with interventional vitrectomy including accelerated nuclear sclerotic cataract formation and retinal detachment. Others9 have tried to develop chorioretinal anastomosis at the site of the venous block. However, others1° are trying to cannulise the blocked central retinal vein. As no single treatment for central retinal vein is yet successful, the authors tried a new modality of treatment in cases of central venous retinal occlusion.

Abstract| Methods and Materials| Observation| Discussion| References |

https://www.high-endrolex.com/21